nodes	percent_of_prediction	percent_of_DWPC	metapath
Estrone—SHBG—Spironolactone—dilated cardiomyopathy	0.258	0.53	CbGbCtD
Estrone—Testolactone—Spironolactone—dilated cardiomyopathy	0.255	0.563	CrCrCtD
Estrone—Testosterone—Spironolactone—dilated cardiomyopathy	0.198	0.437	CrCrCtD
Estrone—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.118	0.243	CbGbCtD
Estrone—ALB—Furosemide—dilated cardiomyopathy	0.0418	0.0858	CbGbCtD
Estrone—ABCB1—Lisinopril—dilated cardiomyopathy	0.0363	0.0746	CbGbCtD
Estrone—ABCB1—Spironolactone—dilated cardiomyopathy	0.032	0.0657	CbGbCtD
Estrone—Breast cancer—Spironolactone—dilated cardiomyopathy	0.00603	0.143	CcSEcCtD
Estrone—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.00251	0.0598	CcSEcCtD
Estrone—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00202	0.0481	CcSEcCtD
Estrone—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00136	0.0324	CcSEcCtD
Estrone—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.00131	0.0311	CcSEcCtD
Estrone—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.0011	0.0262	CcSEcCtD
Estrone—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00104	0.0248	CcSEcCtD
Estrone—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00102	0.0243	CcSEcCtD
Estrone—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.001	0.0239	CcSEcCtD
Estrone—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000924	0.022	CcSEcCtD
Estrone—Purpura—Furosemide—dilated cardiomyopathy	0.000901	0.0214	CcSEcCtD
Estrone—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000898	0.0214	CcSEcCtD
Estrone—Irritability—Furosemide—dilated cardiomyopathy	0.000829	0.0197	CcSEcCtD
Estrone—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000785	0.0187	CcSEcCtD
Estrone—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000756	0.018	CcSEcCtD
Estrone—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000736	0.0175	CcSEcCtD
Estrone—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000665	0.0158	CcSEcCtD
Estrone—Urticaria—Spironolactone—dilated cardiomyopathy	0.000623	0.0148	CcSEcCtD
Estrone—Irritability—Lisinopril—dilated cardiomyopathy	0.000622	0.0148	CcSEcCtD
Estrone—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000568	0.0135	CcSEcCtD
Estrone—Asthma—Lisinopril—dilated cardiomyopathy	0.000563	0.0134	CcSEcCtD
Estrone—Pruritus—Spironolactone—dilated cardiomyopathy	0.000555	0.0132	CcSEcCtD
Estrone—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000552	0.0131	CcSEcCtD
Estrone—Dizziness—Spironolactone—dilated cardiomyopathy	0.000519	0.0123	CcSEcCtD
Estrone—Flatulence—Furosemide—dilated cardiomyopathy	0.000515	0.0123	CcSEcCtD
Estrone—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000503	0.012	CcSEcCtD
Estrone—Depression—Lisinopril—dilated cardiomyopathy	0.000501	0.0119	CcSEcCtD
Estrone—Vomiting—Spironolactone—dilated cardiomyopathy	0.000499	0.0119	CcSEcCtD
Estrone—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000495	0.0118	CcSEcCtD
Estrone—Rash—Spironolactone—dilated cardiomyopathy	0.000495	0.0118	CcSEcCtD
Estrone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000494	0.0118	CcSEcCtD
Estrone—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000492	0.0117	CcSEcCtD
Estrone—Headache—Spironolactone—dilated cardiomyopathy	0.000492	0.0117	CcSEcCtD
Estrone—Nausea—Spironolactone—dilated cardiomyopathy	0.000466	0.0111	CcSEcCtD
Estrone—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000427	0.0102	CcSEcCtD
Estrone—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000426	0.0101	CcSEcCtD
Estrone—Flatulence—Lisinopril—dilated cardiomyopathy	0.000387	0.0092	CcSEcCtD
Estrone—Tension—Lisinopril—dilated cardiomyopathy	0.000385	0.00916	CcSEcCtD
Estrone—Nervousness—Lisinopril—dilated cardiomyopathy	0.000381	0.00907	CcSEcCtD
Estrone—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000377	0.00898	CcSEcCtD
Estrone—Pain—Furosemide—dilated cardiomyopathy	0.000365	0.00868	CcSEcCtD
Estrone—Angioedema—Lisinopril—dilated cardiomyopathy	0.000359	0.00853	CcSEcCtD
Estrone—Urticaria—Furosemide—dilated cardiomyopathy	0.000339	0.00807	CcSEcCtD
Estrone—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000338	0.00803	CcSEcCtD
Estrone—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000334	0.00795	CcSEcCtD
Estrone—Oedema—Lisinopril—dilated cardiomyopathy	0.00032	0.00762	CcSEcCtD
Estrone—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00032	0.00762	CcSEcCtD
Estrone—Pruritus—Furosemide—dilated cardiomyopathy	0.000302	0.00719	CcSEcCtD
Estrone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000292	0.00694	CcSEcCtD
Estrone—Dizziness—Furosemide—dilated cardiomyopathy	0.000282	0.00672	CcSEcCtD
Estrone—Pain—Lisinopril—dilated cardiomyopathy	0.000274	0.00652	CcSEcCtD
Estrone—Vomiting—Furosemide—dilated cardiomyopathy	0.000271	0.00646	CcSEcCtD
Estrone—Rash—Furosemide—dilated cardiomyopathy	0.000269	0.0064	CcSEcCtD
Estrone—Dermatitis—Furosemide—dilated cardiomyopathy	0.000269	0.0064	CcSEcCtD
Estrone—Headache—Furosemide—dilated cardiomyopathy	0.000267	0.00636	CcSEcCtD
Estrone—Urticaria—Lisinopril—dilated cardiomyopathy	0.000254	0.00605	CcSEcCtD
Estrone—Nausea—Furosemide—dilated cardiomyopathy	0.000254	0.00603	CcSEcCtD
Estrone—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000253	0.00602	CcSEcCtD
Estrone—Pruritus—Lisinopril—dilated cardiomyopathy	0.000227	0.00539	CcSEcCtD
Estrone—Dizziness—Lisinopril—dilated cardiomyopathy	0.000212	0.00504	CcSEcCtD
Estrone—Vomiting—Lisinopril—dilated cardiomyopathy	0.000204	0.00484	CcSEcCtD
Estrone—Rash—Lisinopril—dilated cardiomyopathy	0.000202	0.0048	CcSEcCtD
Estrone—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000202	0.0048	CcSEcCtD
Estrone—Headache—Lisinopril—dilated cardiomyopathy	0.000201	0.00477	CcSEcCtD
Estrone—Nausea—Lisinopril—dilated cardiomyopathy	0.00019	0.00453	CcSEcCtD
Estrone—CYP1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.6e-05	0.00408	CbGpPWpGaD
Estrone—ESR1—Leptin signaling pathway—RAC1—dilated cardiomyopathy	7.58e-05	0.00407	CbGpPWpGaD
Estrone—CYP1A1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	7.57e-05	0.00406	CbGpPWpGaD
Estrone—ESR2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	7.53e-05	0.00404	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	7.47e-05	0.00401	CbGpPWpGaD
Estrone—ESR1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	7.43e-05	0.00399	CbGpPWpGaD
Estrone—ESR2—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	7.26e-05	0.00389	CbGpPWpGaD
Estrone—ESR2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	7.26e-05	0.00389	CbGpPWpGaD
Estrone—CYP1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.15e-05	0.00384	CbGpPWpGaD
Estrone—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	7.12e-05	0.00382	CbGpPWpGaD
Estrone—ESR2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	7.12e-05	0.00382	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.02e-05	0.00377	CbGpPWpGaD
Estrone—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	6.66e-05	0.00358	CbGpPWpGaD
Estrone—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	6.48e-05	0.00348	CbGpPWpGaD
Estrone—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	6.21e-05	0.00333	CbGpPWpGaD
Estrone—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	6e-05	0.00322	CbGpPWpGaD
Estrone—SLCO1A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.92e-05	0.00318	CbGpPWpGaD
Estrone—ESR1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	5.83e-05	0.00313	CbGpPWpGaD
Estrone—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	5.79e-05	0.00311	CbGpPWpGaD
Estrone—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.76e-05	0.00309	CbGpPWpGaD
Estrone—SLCO1A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.76e-05	0.00309	CbGpPWpGaD
Estrone—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	5.65e-05	0.00303	CbGpPWpGaD
Estrone—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	5.62e-05	0.00302	CbGpPWpGaD
Estrone—ESR2—Gene Expression—NR3C2—dilated cardiomyopathy	5.56e-05	0.00299	CbGpPWpGaD
Estrone—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	5.54e-05	0.00297	CbGpPWpGaD
Estrone—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	5.52e-05	0.00296	CbGpPWpGaD
Estrone—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	5.48e-05	0.00294	CbGpPWpGaD
Estrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	5.48e-05	0.00294	CbGpPWpGaD
Estrone—SLCO1A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.35e-05	0.00287	CbGpPWpGaD
Estrone—CYP4A11—Metabolism—ANKRD1—dilated cardiomyopathy	5.25e-05	0.00282	CbGpPWpGaD
Estrone—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	5.22e-05	0.0028	CbGpPWpGaD
Estrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	5.22e-05	0.0028	CbGpPWpGaD
Estrone—CYP1B1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	5.22e-05	0.0028	CbGpPWpGaD
Estrone—ESR1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	5.1e-05	0.00273	CbGpPWpGaD
Estrone—SLCO1B1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.06e-05	0.00272	CbGpPWpGaD
Estrone—ESR1—Leptin signaling pathway—RAF1—dilated cardiomyopathy	5.03e-05	0.0027	CbGpPWpGaD
Estrone—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	5.02e-05	0.0027	CbGpPWpGaD
Estrone—CYP4A11—Metabolism—TAZ—dilated cardiomyopathy	4.94e-05	0.00265	CbGpPWpGaD
Estrone—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.92e-05	0.00264	CbGpPWpGaD
Estrone—SLCO1B1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.92e-05	0.00264	CbGpPWpGaD
Estrone—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	4.92e-05	0.00264	CbGpPWpGaD
Estrone—ESR1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	4.85e-05	0.0026	CbGpPWpGaD
Estrone—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	4.82e-05	0.00259	CbGpPWpGaD
Estrone—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	4.78e-05	0.00256	CbGpPWpGaD
Estrone—ESR2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	4.72e-05	0.00253	CbGpPWpGaD
Estrone—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.69e-05	0.00251	CbGpPWpGaD
Estrone—CYP1A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.68e-05	0.00251	CbGpPWpGaD
Estrone—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	4.61e-05	0.00248	CbGpPWpGaD
Estrone—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	4.6e-05	0.00247	CbGpPWpGaD
Estrone—SLCO1B1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.58e-05	0.00246	CbGpPWpGaD
Estrone—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.56e-05	0.00245	CbGpPWpGaD
Estrone—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.56e-05	0.00245	CbGpPWpGaD
Estrone—CYP4A11—Metabolism—SDHA—dilated cardiomyopathy	4.47e-05	0.0024	CbGpPWpGaD
Estrone—CYP1A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.4e-05	0.00236	CbGpPWpGaD
Estrone—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	4.39e-05	0.00236	CbGpPWpGaD
Estrone—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	4.39e-05	0.00235	CbGpPWpGaD
Estrone—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	4.38e-05	0.00235	CbGpPWpGaD
Estrone—ESR1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	4.33e-05	0.00232	CbGpPWpGaD
Estrone—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.27e-05	0.00229	CbGpPWpGaD
Estrone—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.24e-05	0.00227	CbGpPWpGaD
Estrone—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	4.07e-05	0.00218	CbGpPWpGaD
Estrone—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.01e-05	0.00215	CbGpPWpGaD
Estrone—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	3.92e-05	0.00211	CbGpPWpGaD
Estrone—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	3.92e-05	0.0021	CbGpPWpGaD
Estrone—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	3.89e-05	0.00209	CbGpPWpGaD
Estrone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	3.84e-05	0.00206	CbGpPWpGaD
Estrone—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	3.8e-05	0.00204	CbGpPWpGaD
Estrone—ESR1—Regulation of Telomerase—EGFR—dilated cardiomyopathy	3.73e-05	0.002	CbGpPWpGaD
Estrone—ESR1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	3.66e-05	0.00196	CbGpPWpGaD
Estrone—ESR1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.66e-05	0.00196	CbGpPWpGaD
Estrone—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	3.66e-05	0.00196	CbGpPWpGaD
Estrone—ESR2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	3.62e-05	0.00194	CbGpPWpGaD
Estrone—ESR1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.59e-05	0.00193	CbGpPWpGaD
Estrone—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	3.53e-05	0.00189	CbGpPWpGaD
Estrone—ESR2—Gene Expression—NPPA—dilated cardiomyopathy	3.49e-05	0.00188	CbGpPWpGaD
Estrone—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.49e-05	0.00187	CbGpPWpGaD
Estrone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	3.46e-05	0.00185	CbGpPWpGaD
Estrone—CYP1B1—Metabolism—ANKRD1—dilated cardiomyopathy	3.39e-05	0.00182	CbGpPWpGaD
Estrone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	3.38e-05	0.00181	CbGpPWpGaD
Estrone—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	3.38e-05	0.00181	CbGpPWpGaD
Estrone—ALB—Hemostasis—TTN—dilated cardiomyopathy	3.34e-05	0.00179	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—ANKRD1—dilated cardiomyopathy	3.33e-05	0.00179	CbGpPWpGaD
Estrone—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	3.31e-05	0.00178	CbGpPWpGaD
Estrone—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.28e-05	0.00176	CbGpPWpGaD
Estrone—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.24e-05	0.00174	CbGpPWpGaD
Estrone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	3.21e-05	0.00173	CbGpPWpGaD
Estrone—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	3.21e-05	0.00173	CbGpPWpGaD
Estrone—CYP1B1—Metabolism—TAZ—dilated cardiomyopathy	3.18e-05	0.00171	CbGpPWpGaD
Estrone—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	3.14e-05	0.00168	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—TAZ—dilated cardiomyopathy	3.13e-05	0.00168	CbGpPWpGaD
Estrone—ESR2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.08e-05	0.00165	CbGpPWpGaD
Estrone—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	3.08e-05	0.00165	CbGpPWpGaD
Estrone—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.99e-05	0.0016	CbGpPWpGaD
Estrone—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	2.9e-05	0.00155	CbGpPWpGaD
Estrone—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	2.9e-05	0.00155	CbGpPWpGaD
Estrone—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.89e-05	0.00155	CbGpPWpGaD
Estrone—CYP1B1—Metabolism—SDHA—dilated cardiomyopathy	2.88e-05	0.00154	CbGpPWpGaD
Estrone—ESR1—Signaling by ERBB4—RAF1—dilated cardiomyopathy	2.86e-05	0.00153	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—SDHA—dilated cardiomyopathy	2.83e-05	0.00152	CbGpPWpGaD
Estrone—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.81e-05	0.00151	CbGpPWpGaD
Estrone—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.81e-05	0.00151	CbGpPWpGaD
Estrone—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.81e-05	0.00151	CbGpPWpGaD
Estrone—ESR1—Gene Expression—NR3C2—dilated cardiomyopathy	2.81e-05	0.00151	CbGpPWpGaD
Estrone—CYP4A11—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.73e-05	0.00146	CbGpPWpGaD
Estrone—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	2.7e-05	0.00145	CbGpPWpGaD
Estrone—CYP4A11—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.65e-05	0.00142	CbGpPWpGaD
Estrone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	2.64e-05	0.00142	CbGpPWpGaD
Estrone—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	2.62e-05	0.00141	CbGpPWpGaD
Estrone—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.61e-05	0.0014	CbGpPWpGaD
Estrone—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.53e-05	0.00136	CbGpPWpGaD
Estrone—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.46e-05	0.00132	CbGpPWpGaD
Estrone—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.46e-05	0.00132	CbGpPWpGaD
Estrone—ALB—Hemostasis—VCL—dilated cardiomyopathy	2.46e-05	0.00132	CbGpPWpGaD
Estrone—CYP4A11—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.39e-05	0.00128	CbGpPWpGaD
Estrone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	2.38e-05	0.00128	CbGpPWpGaD
Estrone—ESR1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.38e-05	0.00128	CbGpPWpGaD
Estrone—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.29e-05	0.00123	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	2.26e-05	0.00121	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	2.21e-05	0.00119	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	2.21e-05	0.00118	CbGpPWpGaD
Estrone—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	2.2e-05	0.00118	CbGpPWpGaD
Estrone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	2.15e-05	0.00115	CbGpPWpGaD
Estrone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	2.15e-05	0.00115	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	2.12e-05	0.00114	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	2.09e-05	0.00112	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	2.08e-05	0.00112	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	2.07e-05	0.00111	CbGpPWpGaD
Estrone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	2.05e-05	0.0011	CbGpPWpGaD
Estrone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	2.05e-05	0.0011	CbGpPWpGaD
Estrone—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	2.05e-05	0.0011	CbGpPWpGaD
Estrone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.02e-05	0.00108	CbGpPWpGaD
Estrone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.01e-05	0.00108	CbGpPWpGaD
Estrone—ESR1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	1.97e-05	0.00106	CbGpPWpGaD
Estrone—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.96e-05	0.00105	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	1.96e-05	0.00105	CbGpPWpGaD
Estrone—ESR1—Signaling by ERBB4—EGFR—dilated cardiomyopathy	1.96e-05	0.00105	CbGpPWpGaD
Estrone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.94e-05	0.00104	CbGpPWpGaD
Estrone—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	1.93e-05	0.00103	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	1.92e-05	0.00103	CbGpPWpGaD
Estrone—SLCO2B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.9e-05	0.00102	CbGpPWpGaD
Estrone—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	1.9e-05	0.00102	CbGpPWpGaD
Estrone—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.9e-05	0.00102	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	1.88e-05	0.00101	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	1.88e-05	0.00101	CbGpPWpGaD
Estrone—ALB—Metabolism—TAZ—dilated cardiomyopathy	1.79e-05	0.000959	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	1.77e-05	0.000951	CbGpPWpGaD
Estrone—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.77e-05	0.000949	CbGpPWpGaD
Estrone—ESR1—Gene Expression—NPPA—dilated cardiomyopathy	1.76e-05	0.000946	CbGpPWpGaD
Estrone—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.76e-05	0.000942	CbGpPWpGaD
Estrone—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	1.74e-05	0.000936	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.73e-05	0.000926	CbGpPWpGaD
Estrone—CYP1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.71e-05	0.000918	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.68e-05	0.000902	CbGpPWpGaD
Estrone—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.67e-05	0.000894	CbGpPWpGaD
Estrone—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.67e-05	0.000894	CbGpPWpGaD
Estrone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.63e-05	0.000875	CbGpPWpGaD
Estrone—ALB—Metabolism—SDHA—dilated cardiomyopathy	1.62e-05	0.000867	CbGpPWpGaD
Estrone—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.57e-05	0.00084	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	1.56e-05	0.000835	CbGpPWpGaD
Estrone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.55e-05	0.000834	CbGpPWpGaD
Estrone—CYP1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.54e-05	0.000826	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.51e-05	0.000812	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	1.46e-05	0.000785	CbGpPWpGaD
Estrone—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.42e-05	0.00076	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	1.33e-05	0.000713	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	1.32e-05	0.00071	CbGpPWpGaD
Estrone—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	1.28e-05	0.000686	CbGpPWpGaD
Estrone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.26e-05	0.000675	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	1.25e-05	0.000671	CbGpPWpGaD
Estrone—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	1.24e-05	0.000663	CbGpPWpGaD
Estrone—CYP4A11—Metabolism—GPX1—dilated cardiomyopathy	1.21e-05	0.000651	CbGpPWpGaD
Estrone—CYP4A11—Metabolism—CD36—dilated cardiomyopathy	1.18e-05	0.000634	CbGpPWpGaD
Estrone—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.17e-05	0.000626	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	1.13e-05	0.000607	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.11e-05	0.000595	CbGpPWpGaD
Estrone—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.08e-05	0.00058	CbGpPWpGaD
Estrone—CYP4A11—Metabolism—AGT—dilated cardiomyopathy	1.06e-05	0.000571	CbGpPWpGaD
Estrone—ALB—Hemostasis—CD36—dilated cardiomyopathy	1.05e-05	0.000566	CbGpPWpGaD
Estrone—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.05e-05	0.000565	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.03e-05	0.000551	CbGpPWpGaD
Estrone—SLCO1B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.98e-06	0.000536	CbGpPWpGaD
Estrone—ALB—Hemostasis—RAC1—dilated cardiomyopathy	9.94e-06	0.000533	CbGpPWpGaD
Estrone—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.86e-06	0.000529	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.85e-06	0.000529	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.85e-06	0.000529	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	9.65e-06	0.000518	CbGpPWpGaD
Estrone—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.6e-06	0.000515	CbGpPWpGaD
Estrone—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.48e-06	0.000509	CbGpPWpGaD
Estrone—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.24e-06	0.000496	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.16e-06	0.000491	CbGpPWpGaD
Estrone—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	8.99e-06	0.000482	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.87e-06	0.000476	CbGpPWpGaD
Estrone—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	8.75e-06	0.00047	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	8.72e-06	0.000468	CbGpPWpGaD
Estrone—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.64e-06	0.000464	CbGpPWpGaD
Estrone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	8.63e-06	0.000463	CbGpPWpGaD
Estrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	8.22e-06	0.000441	CbGpPWpGaD
Estrone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.07e-06	0.000433	CbGpPWpGaD
Estrone—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	7.88e-06	0.000423	CbGpPWpGaD
Estrone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.86e-06	0.000422	CbGpPWpGaD
Estrone—CYP1B1—Metabolism—GPX1—dilated cardiomyopathy	7.82e-06	0.00042	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—GPX1—dilated cardiomyopathy	7.68e-06	0.000412	CbGpPWpGaD
Estrone—CYP1B1—Metabolism—CD36—dilated cardiomyopathy	7.62e-06	0.000409	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.58e-06	0.000407	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—CD36—dilated cardiomyopathy	7.48e-06	0.000402	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.19e-06	0.000386	CbGpPWpGaD
Estrone—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	7.11e-06	0.000382	CbGpPWpGaD
Estrone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.08e-06	0.00038	CbGpPWpGaD
Estrone—ABCG2—Metabolism—CD36—dilated cardiomyopathy	6.93e-06	0.000372	CbGpPWpGaD
Estrone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.9e-06	0.00037	CbGpPWpGaD
Estrone—CYP1B1—Metabolism—AGT—dilated cardiomyopathy	6.86e-06	0.000368	CbGpPWpGaD
Estrone—SLCO1B1—Metabolism—AGT—dilated cardiomyopathy	6.74e-06	0.000362	CbGpPWpGaD
Estrone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.72e-06	0.00036	CbGpPWpGaD
Estrone—ALB—Hemostasis—RAF1—dilated cardiomyopathy	6.59e-06	0.000354	CbGpPWpGaD
Estrone—ABCG2—Metabolism—AGT—dilated cardiomyopathy	6.24e-06	0.000335	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.18e-06	0.000331	CbGpPWpGaD
Estrone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.05e-06	0.000324	CbGpPWpGaD
Estrone—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.7e-06	0.000306	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—RAC1—dilated cardiomyopathy	5.58e-06	0.000299	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—AGT—dilated cardiomyopathy	5.33e-06	0.000286	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	5.22e-06	0.00028	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	5.11e-06	0.000274	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	5.1e-06	0.000274	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	5.08e-06	0.000273	CbGpPWpGaD
Estrone—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5e-06	0.000268	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	4.97e-06	0.000267	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	4.96e-06	0.000266	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	4.82e-06	0.000258	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	4.69e-06	0.000252	CbGpPWpGaD
Estrone—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	4.57e-06	0.000245	CbGpPWpGaD
Estrone—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	4.48e-06	0.00024	CbGpPWpGaD
Estrone—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	4.47e-06	0.00024	CbGpPWpGaD
Estrone—ALB—Metabolism—GPX1—dilated cardiomyopathy	4.39e-06	0.000236	CbGpPWpGaD
Estrone—ALB—Metabolism—CD36—dilated cardiomyopathy	4.28e-06	0.000229	CbGpPWpGaD
Estrone—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	4.22e-06	0.000227	CbGpPWpGaD
Estrone—ALB—Metabolism—AGT—dilated cardiomyopathy	3.85e-06	0.000207	CbGpPWpGaD
Estrone—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	3.85e-06	0.000206	CbGpPWpGaD
Estrone—ABCB1—Metabolism—CD36—dilated cardiomyopathy	3.75e-06	0.000201	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.7e-06	0.000199	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	3.59e-06	0.000193	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	3.5e-06	0.000188	CbGpPWpGaD
Estrone—ABCB1—Metabolism—AGT—dilated cardiomyopathy	3.37e-06	0.000181	CbGpPWpGaD
Estrone—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	3.15e-06	0.000169	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	3.07e-06	0.000165	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	2.99e-06	0.00016	CbGpPWpGaD
Estrone—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	2.69e-06	0.000144	CbGpPWpGaD
Estrone—ESR1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.54e-06	0.000136	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.37e-06	0.000127	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.31e-06	0.000124	CbGpPWpGaD
Estrone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.08e-06	0.000112	CbGpPWpGaD
